Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bone Biologics Corp

2.86
-0.0600-2.05%
Post-market: 2.85-0.0100-0.35%19:44 EDT
Volume:85.95K
Turnover:249.22K
Market Cap:4.59M
PE:-0.14
High:2.97
Open:2.97
Low:2.84
Close:2.92
Loading ...
Jun 28, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Jun 07, 2021

Major Issues Report

8-K - Current report
May 21, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 15, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 15, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 15, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 15, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 17, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 09, 2020

Major Issues Report

8-K - Current report
Nov 14, 2019

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 25, 2019

Major Issues Report

8-K - Current report
Aug 14, 2019

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2019

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jul 17, 2019

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 28, 2019

Major Issues Report

8-K - Current report
Jun 21, 2019

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 24, 2019

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 14, 2019

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 16, 2019

Major Issues Report

8-K - Current report